Navigation Links
Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine
Date:7/31/2014

ts of which were recently published in the journal Human Vaccines & Immunotherapeutics.

HPV-023

For this study (HPV-023), participants from Brazil were invited to continue follow-up. 437 women from five centers participated in this 36-month long-term follow-up for 113 months (9.4 years). The aim of the study was to evaluate efficacy against HPV-16/18 infection and associated cyto-histopathological abnormalities, persistence of immunogenicity, and safety of the vaccine. During HPV-023, anti-HPV-16/18 antibodies were measured annually by enzyme-linked immunosorbent assay (ELISA) and pseudovirion-based neutralisation assay (PBNA). Cervical samples were tested for HPV DNA every 6 months, and cyto-pathological examinations were performed annually.

Efficacy against HPV-16/18 infections

During HPV-023, no new HPV-16/18-associated infections or cyto-histopathological abnormalities occurred in the vaccine group. In particular, VE against HPV-16/18 incident infection was 100%. VE was 95.6% against incident infection over 9.4 years. Looking at secondary endpoints, the data showed no cases of either 6- or 12-month HPV-16/18 persistent infection in the vaccine group, versus four cases and one case, respectively, in the placebo group during the 26-months follow-up.

Efficacy against cyto-histopathological abnormalities

VE against cyto-histopathological abnormalities was another secondary endpoint of the study. VE was 97.1% against atypical squamous cells of undetermined significance (ASC-US), 95% against low-grade squamous intraepithelial lesion (LISL), and 100% against cervical intraepithelial neoplasia grade 1 (CIN1+) and grade 2 (CIN2+) associated with HPV-16/18.

Immunogenicity

All vaccines remained seropositive to HPV-16/18, with antibody titers remaining several folds above natural infection
'/>"/>

Contact: Andrew Thompson
andrew@landesbioscience.com
Landes Bioscience
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. UGA study finds theres not always safety in numbers when it comes to extinction risk
2. Sensitive test helps improve vaccine safety
3. NIH funds development of tissue chips to help predict drug safety
4. Jeff Crandall Honored With SAE International Arnold W. Siegel International Transportation Safety Award
5. INTEGRIS Health Puts Patient Safety in the Palm of Your Hand
6. Questions about biosafety? Ask a biosafety expert
7. Climate change impacts to US coasts threaten public health, safety and economy
8. Masked mold toxins in food should be included in safety regulations
9. Additional research must be done to ensure safety of pit latrines, new study says
10. Revolutionary Face Recognition Media Exploitation System Now Available to Enhance Public Safety in Europe
11. RNA-interference pesticides will need special safety testing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2015)... June 24, 2015 This report provides market ... next six years. It contains an analysis of the ... with their impact from the short, medium, and long ... the industry, market, and technology trends that currently, prevail ... of concerned authorities to efficiently manage the increasing marine ...
(Date:6/24/2015)... June 22, 2015 ... addition of the "Huawei Ascend Mate 7 ... to their offering. Huawei,s technological choice ... opposite direction than Apple,s and Samsung,s one. The ... developed by Fingerprint Cards, a main actor in ...
(Date:6/23/2015)... , June 23, 2015   MedNet ... that supports the entire spectrum of clinical research, ... ™ , the company,s intuitive, flexible ... awarded a Silver 2015 Stevie® Award by the ... Products & Services Website category.  The American Business ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Huawei Ascend Mate 7 Fingerprint Sensor - Reverse Costing Analysis 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... Carbon dioxide (CO2) distinguishes itself as the fastest growing ... regulation of CO2 emissions depends on our ability to ... source of the increase. Until the late ... Hawaii, many questioned whether the industrial revolution and the ...
... new study has identified the first common gene variants ... significant risk factor for heart attack, stroke and kidney ... journal Nature Genetics identifies variants in genes ... also appear to influence blood pressure levels, an association ...
... well as how their brains operate, a study at the ... symposium, "Social Emotion and the Brain," at the annual meeting ... the first to use fMRI scans to study the connections ... brain. Combining fMRI scans with data relevant to social behavior ...
Cached Biology News:Carbon accounting from atmospheric measurements -- the aircraft perspective 2Common gene variants increase risk of hypertension, may lead to new therapies 2Researchers shed new light on connection between brain and loneliness 2Researchers shed new light on connection between brain and loneliness 3
(Date:7/7/2015)... YORK , July 7, 2015 ... Biotechnologies - Gene Therapy Market Analysis" report is ... the gene therapy field. Using detailed company data, ... GlobalData provides an in-depth analysis of the current ... market. The report discusses the key factors shaping ...
(Date:7/7/2015)... Richmond, BC (PRWEB) , ... July 07, 2015 ... ... highlighting early HIV detection using INSTI HIV-1/HIV-2 Antibody Test was accepted for presentation ... and Prevention in Vancouver. The results will be presented Wednesday, July 22nd from ...
(Date:7/7/2015)... ... ... uBiome, the leading microbial genomics company, is offering talented researchers with big ... laboratory analysis. The goal is to fast-track a study with the greatest potential to ... dashboard, enabling them to view and compare the results of their study, as well ...
(Date:7/7/2015)... ... July 07, 2015 , ... The ... barriers to innovation in life science R&D, has attracted a number of new ... another top ten pharmaceutical company joining as a Core member, and DNAnexus and ...
Breaking Biology Technology:PharmaSphere: Emerging Biotechnologies - Gene Therapy Market Analysis 2bioLytical to Present Findings of Early HIV Detection 2bioLytical to Present Findings of Early HIV Detection 3uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3Pistoia Alliance Continues to Attract New Members 2
... , , , ATLANTA and ... CRY ) an implantable biological medical device and cardiovascular ... BioFoam (R) Surgical Matrix, which received CE mark ... procedure following tumor removal as a supplemental measure to promote hemostasis ...
... , COLUMBIA, Md., Sept. 10 DHA omega-3 innovator ... (Nasdaq: MATK ), announced today it has resolved a ... action for infringement filed in the High Court of Strasbourg, France. ... agreement between Martek and Capsugel France, Capsugel and all of its ...
... AUSTIN, Texas, Sept. 10 , , WHO: Panel ... , WHEN: Tuesday, September 15th , , ... 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries , ... TOPIC: Cost-Benefit Analysis of In-house eDiscovery Tools vs. Outsourcing Help , ...
Cached Biology Technology:CryoLife Announces First Clinical Use of BioFoam(R) 2CryoLife Announces First Clinical Use of BioFoam(R) 3CryoLife Announces First Clinical Use of BioFoam(R) 4CryoLife Announces First Clinical Use of BioFoam(R) 5Martek Announces Settlement of Patent Dispute with Capsugel France 2StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference 2
Hamartin/TSC1 (1B2) Mouse mAb Ship: Hot Store: -20 C...
Blank Calibration Particles, 3.0-3.4 mu m 5 ml...
synaptotagmin XIV-like [Source:RefSeq_peptide;Acc:NP_114120] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Alexa Fluor 647 anti-mouse IL-12 (Interleukin-12) / IL-23 (Interleukin-23) p40 25 ug...
Biology Products: